Shares of Caladrius Biosciences Inc. (CLBS) are down 25 percent year-to-date while the iShares Nasdaq Biotechnology ETF (IBB), a bellwether of investor sentiment, is up nearly 15 percent for the same period.
from RTT - Biotech https://ift.tt/35a4ASv
via IFTTT
No comments:
Post a Comment